Dr. Robert C. Martin II, MD
Surgical Oncology (Surgical Oncology Physician)
- Medicare participating
At a glance
- Medical school
- University of Louisville School of Medicine (1995)
- Years since graduation
- 31
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 216
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1995Medical school: University of Louisville School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Surgical Oncology Physician primary
KY license 32503 -
Surgery Physician
KY license 32503
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Norton Hospitals, Inc Louisville, KY
- Uofl Health - Jewish Hospital and Mary & Elizabeth Hospital Louisville, KY
- University of Louisville Hospital Louisville, KY
- Norton Clark Hospital Jeffersonville, IN
Medical groups
- University of Louisville Physicians Inc (1,445 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 216
- Services billed
- 577
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 116 | 79 |
| Established patient office or other outpatient visit, 20-29 minutes | 93 | 70 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 58 | 20 |
| Established patient office or other outpatient visit, 40-54 minutes | 53 | 44 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 49 | 24 |
| New patient office or other outpatient visit, 60-74 minutes | 35 | 35 |
| New patient office or other outpatient visit, 45-59 minutes | 32 | 32 |
| Insertion of central venous tube with port (5 years or older) | 12 | 12 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 12 | 12 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Pantoprazole Sodium Other prescribers in Louisville, KY | 61 |
| Creon (lipase/protease/amylase) Other prescribers in Louisville, KY | 50 |
| Prednisone Other prescribers in Louisville, KY | 22 |
| Omeprazole Other prescribers in Louisville, KY | 14 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 22 payments worth $36,970 in total to this clinician.
| Angiodynamics, Inc. | $36,340 |
|---|---|
| AstraZeneca Pharmaceuticals LP | $269 |
| Galvanize Therapeutics, Inc | $214 |
| Ethicon US, LLC | $89.68 |
| AbbVie Inc. | $40.48 |
| Novo Nordisk Inc | $16.74 |
| Consulting Fee | $33,580 |
|---|---|
| Travel and Lodging | $2,426 |
| Food and Beverage | $964 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Angiodynamics, Inc. May 2, 2025 | Consulting Fee NANOKNIFE · OS | $8,861 |
| Angiodynamics, Inc. Mar 21, 2025 | Consulting Fee NANOKNIFE · OS | $7,125 |
| Angiodynamics, Inc. Jun 6, 2025 | Consulting Fee NANOKNIFE · OS | $6,750 |
| Angiodynamics, Inc. Apr 25, 2025 | Consulting Fee NANOKNIFE · OS | $4,400 |
| Angiodynamics, Inc. Jul 25, 2025 | Consulting Fee NANOKNIFE · OS | $3,875 |
| Angiodynamics, Inc. Sep 19, 2025 | Consulting Fee NANOKNIFE · OS | $2,300 |
| Angiodynamics, Inc. Apr 17, 2025 | Travel and Lodging NANOKNIFE · OS · travel to TAMPA, FL · in-kind | $869 |
| Angiodynamics, Inc. Mar 7, 2025 | Travel and Lodging NANOKNIFE · OS · travel to HONG KONG, Hong Kong · in-kind | $496 |
| Angiodynamics, Inc. May 6, 2025 | Travel and Lodging NANOKNIFE · OS · travel to ALBANY, NY · in-kind | $366 |
| Angiodynamics, Inc. May 6, 2025 | Travel and Lodging NANOKNIFE · OS · travel to ALBANY, NY · in-kind | $362 |
All 14 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Angiodynamics, Inc. Sep 19, 2025 | Consulting Fee NANOKNIFE · OS | $2,300 |
| AstraZeneca Pharmaceuticals LP Sep 11, 2025 | Consulting Fee IMFINZI · Oncology | $269 |
| Angiodynamics, Inc. Jul 25, 2025 | Consulting Fee NANOKNIFE · OS | $3,875 |
| Angiodynamics, Inc. Jun 6, 2025 | Consulting Fee NANOKNIFE · OS | $6,750 |
| Angiodynamics, Inc. Jun 6, 2025 | Travel and Lodging NANOKNIFE · OS · travel to SARATOGA SPRINGS, NY | $94.58 |
| Angiodynamics, Inc. May 6, 2025 | Travel and Lodging NANOKNIFE · OS · travel to ALBANY, NY · in-kind | $366 |
| Angiodynamics, Inc. May 6, 2025 | Travel and Lodging NANOKNIFE · OS · travel to ALBANY, NY · in-kind | $362 |
| Angiodynamics, Inc. May 2, 2025 | Consulting Fee NANOKNIFE · OS | $8,861 |
| Angiodynamics, Inc. Apr 25, 2025 | Consulting Fee NANOKNIFE · OS | $4,400 |
| Angiodynamics, Inc. Apr 17, 2025 | Travel and Lodging NANOKNIFE · OS · travel to TAMPA, FL · in-kind | $869 |
| Angiodynamics, Inc. Apr 17, 2025 | Travel and Lodging NANOKNIFE · OS · travel to FORT WORTH, TX · in-kind | $207 |
| Angiodynamics, Inc. Mar 27, 2025 | Travel and Lodging NANOKNIFE · OS · travel to HONG KONG, Hong Kong · in-kind | $31.33 |
| Angiodynamics, Inc. Mar 21, 2025 | Consulting Fee NANOKNIFE · OS | $7,125 |
| Angiodynamics, Inc. Mar 7, 2025 | Travel and Lodging NANOKNIFE · OS · travel to HONG KONG, Hong Kong · in-kind | $496 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 4 industry-funded studies in 2025, from 3 companies. The companies reported $109,608 in research payments for these studies, mostly to the institutions running them.
- Immuno IIT
Angiodynamics, Inc. - DIRECT
Angiodynamics, Inc. - A Phase 3 Double-blinded, Two-arm Study to Evaluate the Safety and Efficacy of Pembrolizumab MK-3475 versus Placebo as Adjuvant Therapy in Participants with Hepatocellular Carcinoma and Complete Radiological Response …
Merck Sharp & Dohme LLC - A Study to Evaluate Nivolumab in the Treatment of Early Stage Esophageal or Gastroesophageal Cancer
E.r. Squibb & Sons, L.l.c. · Terminated · NCT05780736
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.